Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Oligonucleotide sequences targeting transcription factor TSC22D4 for the treatment of insulin resistance

Oligonucleotide sequences targeting transcription factor TSC22D4 for the treatment of insulin resistance

US Patent 10676739 · Granted Jun 9, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Oligonucleotide sequences targeting transcription factor TSC22D4 for the treatme2021
Oligonucleotide sequences targeting transcription factor TSC22D4 for the treatme2021
Oligonucleotide sequences targeting transcription factor TSC22D4 for the treatme2021
MicroRNAs modulating the effect of glucocorticoid signaling2018
MicroRNAs modulating the effect of glucocorticoid signaling2018
Treatment of insulin resistance through inhibitors of transcription factor TSC222018
Treatment of insulin resistance through inhibitors of transcription factor TSC222018
Protein kinase B/Akt modulators and methods for the use thereof2007
Methods for indentifying compounds that modulate gluconeogenesis through the bin2005